Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Mais filtros












Intervalo de ano de publicação
2.
Sci Rep ; 14(1): 9820, 2024 04 29.
Artigo em Inglês | MEDLINE | ID: mdl-38684767

RESUMO

In critically ill patients, overweight and obesity are associated with acute respiratory distress syndrome and acute kidney injury (AKI). However, the effect of obesity on ischemia-reperfusion injury (IRI)-induced AKI is unknown. We hypothesized that obesity would aggravate renal IRI in mice. We fed mice a standard or high-fat diet for eight weeks. The mice were divided into four groups and submitted to sham surgery or IRI: obese, normal, normal + IRI, obese, and obese + IRI. All studies were performed 48 h after the procedures. Serum glucose, cholesterol, and creatinine clearance did not differ among the groups. Survival and urinary osmolality were lower in the obese + IRI group than in the normal + IRI group, whereas urinary neutrophil gelatinase-associated lipocalin levels, tubular injury scores, and caspase 3 expression were higher. Proliferating cell nuclear antigen expression was highest in the obese + IRI group, as were the levels of oxidative stress (urinary levels of thiobarbituric acid-reactive substances and renal heme oxygenase-1 protein expression), whereas renal Klotho protein expression was lowest in that group. Expression of glutathione peroxidase 4 and peroxiredoxin 6, proteins that induce lipid peroxidation, a hallmark of ferroptosis, was lower in the obese + IRI group. Notably, among the mice not induced to AKI, macrophage infiltration was greater in the obese group. In conclusion, greater oxidative stress and ferroptosis might aggravate IRI in obese individuals, and Klotho could be a therapeutic target in those with AKI.


Assuntos
Injúria Renal Aguda , Obesidade , Estresse Oxidativo , Traumatismo por Reperfusão , Animais , Injúria Renal Aguda/etiologia , Injúria Renal Aguda/metabolismo , Injúria Renal Aguda/patologia , Traumatismo por Reperfusão/complicações , Traumatismo por Reperfusão/metabolismo , Traumatismo por Reperfusão/patologia , Obesidade/complicações , Obesidade/metabolismo , Camundongos , Masculino , Dieta Hiperlipídica/efeitos adversos , Modelos Animais de Doenças , Camundongos Endogâmicos C57BL , Glucuronidase/metabolismo , Rim/metabolismo , Rim/patologia
3.
Sci Rep ; 12(1): 20443, 2022 11 28.
Artigo em Inglês | MEDLINE | ID: mdl-36443404

RESUMO

Hemorrhagic shock (HS), a major cause of trauma-related mortality, is mainly treated by crystalloid fluid administration, typically with lactated Ringer's (LR). Despite beneficial hemodynamic effects, such as the restoration of mean arterial pressure (MAP), LR administration has major side effects, including organ damage due to edema. One strategy to avoid such effects is pre-hospitalization intravenous administration of the potent vasoconstrictor terlipressin, which can restore hemodynamic stability/homeostasis and has anti-inflammatory effects. Wistar rats were subjected to HS for 60 min, at a target MAP of 30-40 mmHg, thereafter being allocated to receive LR infusion at 3 times the volume of the blood withdrawn (liberal fluid management); at 2 times the volume (conservative fluid management), plus terlipressin (10 µg/100 g body weight); and at an equal volume (conservative fluid management), plus terlipressin (10 µg/100 g body weight). A control group comprised rats not subjected to HS and receiving no fluid resuscitation or treatment. At 15 min after fluid resuscitation/treatment, the blood previously withdrawn was reinfused. At 24 h after HS, MAP was higher among the terlipressin-treated animals. Terlipressin also improved post-HS survival and provided significant improvements in glomerular/tubular function (creatinine clearance), neutrophil gelatinase-associated lipocalin expression, fractional excretion of sodium, aquaporin 2 expression, tubular injury, macrophage infiltration, interleukin 6 levels, interleukin 18 levels, and nuclear factor kappa B expression. In terlipressin-treated animals, there was also significantly higher angiotensin II type 1 receptor expression and normalization of arginine vasopressin 1a receptor expression. Terlipressin associated with conservative fluid management could be a viable therapy for HS-induced acute kidney injury, likely attenuating such injury by modulating the inflammatory response via the arginine vasopressin 1a receptor.


Assuntos
Injúria Renal Aguda , Choque Hemorrágico , Ratos , Animais , Terlipressina/uso terapêutico , Choque Hemorrágico/complicações , Choque Hemorrágico/tratamento farmacológico , Ratos Wistar , Injúria Renal Aguda/tratamento farmacológico , Injúria Renal Aguda/etiologia , Lactato de Ringer , Receptores de Vasopressinas , Arginina Vasopressina
4.
Am J Case Rep ; 23: e933957, 2022 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-35094004

RESUMO

BACKGROUND Distal renal tubular acidosis (dRTA) is a defect in the urinary acidification process that limits the elimination of protons [H+] by alpha intercalated cells in the collecting tubules, with consequent metabolic acidosis with a normal plasma anion gap. The relationship between this tubulopathy and immune-mediated diseases like Sjögren syndrome, rheumatoid arthritis, autoimmune hepatitis, primary biliary cirrhosis, systemic lupus erythematosus, and thyroiditis is well known. Further, the pathophysiological mechanisms are diverse, but, unfortunately, many are not yet fully understood. We report 3 cases of dRTA in patients with different autoimmune diseases and review the pathophysiological mechanisms already described. CASE REPORT The first case involved a 29-year-old woman with autoimmune hepatitis. She had metabolic acidosis with persistent hypokalemia, and a kidney stone was also identified. The second case involved a 67-year-old woman diagnosed with rheumatoid arthritis. She had metabolic acidosis with hypokalemia. The third case involved a 30-year-old woman with Sjögren syndrome and persistent metabolic acidosis. In addition to the presence of metabolic acidosis with a normal plasma anion gap, all 3 patients exhibited urine with a supraphysiologic pH (above 5.3). CONCLUSIONS Autoimmune diseases may be associated with deficits in urinary acidification with consequent metabolic acidosis and, therefore, systemic repercussions. This association must be remembered and researched because correct diagnosis and treatment will serve to reduce complications.


Assuntos
Acidose Tubular Renal , Hepatite Autoimune , Hipopotassemia , Cálculos Renais , Síndrome de Sjogren , Acidose Tubular Renal/complicações , Acidose Tubular Renal/diagnóstico , Adulto , Idoso , Feminino , Humanos , Hipopotassemia/etiologia , Síndrome de Sjogren/complicações , Síndrome de Sjogren/diagnóstico
5.
J. bras. nefrol ; 43(1): 103-109, Jan.-Mar. 2021. tab, graf
Artigo em Inglês, Português | LILACS | ID: biblio-1154658

RESUMO

Abstract Thiazide and thiazide-like diuretics are widely used for the management of hypercalciuria among stone-forming patients. Although the effects of different thiazides should be relatively similar in terms of prevention of stone recurrence, their potency and side effects may differ. However, there is scarce data concerning the metabolic and bone effects of these agents among recurrent nephrolithiasis patients with hypercalciuria. The aim of this update article was to compare our experience in the use of thiazide and thiazide- like diuretics with that of the current literature, concerning their anticalciuric properties and consequent reduction of recurrent stone formation. Their impact on bone mass and potential side effects were also discussed.


Resumo Diuréticos tiazídicos e tiazídicos-like são amplamente usados para o tratamento da hipercalciúria em pacientes com formação de cálculos. Embora os efeitos dos diferentes tiazídicos devam ser relativamente semelhantes em termos de prevenção da recorrência do cálculo, sua potência e efeitos colaterais podem ser diferentes. No entanto, há poucos dados sobre os efeitos metabólicos e ósseos desses agentes em pacientes com nefrolitíase recorrente com hipercalciúria. O objetivo deste artigo de atualização foi comparar nossa experiência quanto ao uso de tiazídicos e tiazídicos-like com a publicada na literatura atual, no que diz respeito às suas propriedades anticalciúricas e consequente redução da formação de cálculos recorrentes. Discutimos também seu impacto na massa óssea e potenciais efeitos colaterais.


Assuntos
Humanos , Cálculos Renais , Nefrolitíase/tratamento farmacológico , Recidiva , Diuréticos/uso terapêutico , Tiazidas/uso terapêutico
6.
J Bras Nefrol ; 43(2): 200-206, 2021.
Artigo em Inglês, Português | MEDLINE | ID: mdl-33577639

RESUMO

BACKGROUND AND OBJECTIVE: Magnesium ammonium phosphate stones (MAP), also known as struvite stones, are associated with urinary infection and impairment of renal unit. The aim of this study is to evaluate the urinary metabolic risk factors for recurrence of renal calculi in patients submitted to nephrectomy due to MAP stones. METHODS: We retrospectively reviewed the charts of patients > 18 years old submitted to total nephrectomy due to pure MAP stones and pure calcium oxalate (CaOx) stones from July 2006 to July 2016. Urinary metabolic parameters were assessed through 24-hour urine exams ≥ 3 months after nephrectomy. Urinary metabolic parameters and new event related to lithiasis were compared. RESULTS: Twenty-eight and 39 patients were included in MAP and CaOx group, respectively. Abnormalities in 24-hour urine samples were similar between groups. Hypercalciuria occurred in 7.1 and 10.3% of patients in MAP and CaOx group, respectively (p = 0.66), whereas hypocitraturia was present in 65.2 and 59.0% of patients with MAP and CaOx group, respectively (p = 0.41). No significant difference in new events was found between MAP and CaOx groups (17.9 vs. 23.1%, respectively; p = 0.60). CONCLUSION: A 24-hour urine evaluation should be offered to patients submitted to nephrectomy due to pure MAP stones in order to detect metabolic risk, improve treatment, and prevent stone recurrence.


Assuntos
Oxalato de Cálcio , Cálculos Renais , Adolescente , Humanos , Rim , Cálculos Renais/epidemiologia , Cálculos Renais/cirurgia , Estudos Retrospectivos , Estruvita
7.
J Bras Nefrol ; 43(1): 103-109, 2021.
Artigo em Inglês, Português | MEDLINE | ID: mdl-33179717

RESUMO

Thiazide and thiazide-like diuretics are widely used for the management of hypercalciuria among stone-forming patients. Although the effects of different thiazides should be relatively similar in terms of prevention of stone recurrence, their potency and side effects may differ. However, there is scarce data concerning the metabolic and bone effects of these agents among recurrent nephrolithiasis patients with hypercalciuria. The aim of this update article was to compare our experience in the use of thiazide and thiazide- like diuretics with that of the current literature, concerning their anticalciuric properties and consequent reduction of recurrent stone formation. Their impact on bone mass and potential side effects were also discussed.


Assuntos
Cálculos Renais , Nefrolitíase , Diuréticos/uso terapêutico , Humanos , Nefrolitíase/tratamento farmacológico , Recidiva , Tiazidas/uso terapêutico
8.
Am J Physiol Regul Integr Comp Physiol ; 318(1): R135-R147, 2020 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-31596111

RESUMO

Sepsis induces organ dysfunction due to overexpression of the inflammatory host response, resulting in cardiopulmonary and autonomic dysfunction, thus increasing the associated morbidity and mortality. Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) express genes and secrete factors with anti-inflammatory properties, neurological and immunological protection, as well as improve survival in experimental sepsis. The cholinergic anti-inflammatory pathway (CAP) is mediated by α7-nicotinic acetylcholine receptors (α7nAChRs), which play an important role in the control of systemic inflammation. We hypothesized that WJ-MSCs attenuate sepsis-induced organ injury in the presence of an activated CAP pathway. To confirm our hypothesis, we evaluated the effects of WJ-MSCs as a treatment for cardiopulmonary injury and on neuroimmunomodulation. Male Wistar rats were randomly divided into four groups: control (sham-operated); cecal ligation and puncture (CLP) alone; CLP+WJ-MSCs (1 × 106 cells, at 6 h post-CLP); and CLP+methyllycaconitine (MLA)+WJ-MSCs (5 mg/kg body wt, at 5.5 h post-CLP, and 1 × 106 cells, at 6 h post-CLP, respectively). All experiments, including the assessment of echocardiographic parameters and heart rate variability, were performed 24 h after CLP. WJ-MSC treatment attenuated diastolic dysfunction and restored baroreflex sensitivity. WJ-MSCs also increased cardiac sympathetic and cardiovagal activity. WJ-MSCs reduced leukocyte infiltration and proinflammatory cytokines, effects that were abolished by administration of a selective α7nAChR antagonist (MLA). In addition, WJ-MSC treatment also diminished apoptosis in the lungs and spleen. In cardiac and splenic tissue, WJ-MSCs downregulated α7nAChR expression, as well as reduced the phospho-STAT3-to-total STAT3 ratio in the spleen. WJ-MSCs appear to protect against sepsis-induced organ injury by reducing systemic inflammation, at least in part, via a mechanism that is dependent on an activated CAP.


Assuntos
Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais/fisiologia , Neuroimunomodulação , Sepse/terapia , Geleia de Wharton/citologia , Animais , Citocinas , Humanos , Masculino , Miocárdio/metabolismo , Distribuição Aleatória , Ratos , Ratos Wistar , Fator de Transcrição STAT3/genética , Fator de Transcrição STAT3/metabolismo , Baço/metabolismo , Receptor Nicotínico de Acetilcolina alfa7/genética , Receptor Nicotínico de Acetilcolina alfa7/metabolismo
9.
Clin J Am Soc Nephrol ; 9(7): 1263-70, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24763863

RESUMO

BACKGROUND AND OBJECTIVES: Increased bone resorption, low bone formation, and abnormal mineralization have been described in stone formers with idiopathic hypercalciuria. It has been previously shown that the receptor activator of NF-κB ligand mediates bone resorption in idiopathic hypercalciuria (IH). The present study aimed to determine the expression of fibroblast growth factor 23 (FGF-23), vitamin D receptor (VDR), and sclerostin in bone tissue from IH stone formers. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Immunohistochemical analysis was performed in undecalcified bone samples previously obtained for histomorphometry from 30 transiliac bone biopsies of idiopathic hypercalciuria stone-forming patients between 1992 and 2002 and 33 healthy individuals (controls). Serum parameters were obtained from their medical records. RESULTS: Histomorphometry disclosed 21 IH patients with high and 9 IH patients with normal bone resorption. Importantly, eroded surfaces (ES/BS) from IH patients but not controls were significantly correlated with VDR immunostaining in osteoblasts (r=0.51; P=0.004), sclerostin immunostaining in osteocytes (r=0.41; P=0.02), and serum 1,25-dihydroxyvitamin D (r=0.55; P<0.01). Of note, both VDR and sclerostin immunostaining were significantly correlated with serum 1,25-dihydroxyvitamin D in IH patients (r=0.52; P=0.01 and r=0.53; P=0.02, respectively), although VDR and sclerostin expression did not differ between IH and controls. IH patients with high bone resorption exhibited a significantly stronger sclerostin immunostaining than IH patients with normal bone resorption. FGF-23 expression in osteocytes from IH patients did not differ from controls and was not correlated with any histomorphometric parameter. CONCLUSIONS: These findings suggest the contribution of VDR and sclerostin, as well as 1,25-dihydroxyvitamin D, to increase bone resorption in idiopathic hypercalciuria but do not implicate FGF-23 in the bone alterations seen in these patients.


Assuntos
Proteínas Morfogenéticas Ósseas/análise , Fatores de Crescimento de Fibroblastos/análise , Hipercalciúria/metabolismo , Ílio/química , Receptores de Calcitriol/análise , Urolitíase/metabolismo , Proteínas Adaptadoras de Transdução de Sinal , Adulto , Reabsorção Óssea/metabolismo , Reabsorção Óssea/fisiopatologia , Feminino , Fator de Crescimento de Fibroblastos 23 , Marcadores Genéticos , Humanos , Hipercalciúria/diagnóstico , Hipercalciúria/fisiopatologia , Ílio/fisiopatologia , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Osteoblastos/química , Osteócitos/química , Estudos Retrospectivos , Urolitíase/diagnóstico , Urolitíase/fisiopatologia , Vitamina D/análogos & derivados , Vitamina D/sangue
10.
J. bras. nefrol ; 31(1): 55-61, jan.-mar. 2009. tab
Artigo em Português | LILACS | ID: lil-595087

RESUMO

Pacientes com cálculo ureteral tipicamente apresentam cólica renal consequente à obstrução do trato urinário. Uma vez controlada a crise dolorosa, um plano terapêutico deve ser estabelecido. A tomografia computadorizada (TC) helicoidal de abdômen e pelve sem contraste endovenoso é o exame de imagem de eleição. O tratamento da litíase ureteral pode ser conservador ou interventivo.Bloqueadores alfa-adrenérgicos são as drogas mais utilizadas para o tratamento clínico expulsivo. Para cálculos com pequena probabilidade de eliminação espontânea devido ao seu tamanho e/ou localização, indica-se tratamento interventivo, realizado através de litotripsia extracorpórea por ondas de choque, endourologia ou excepcionalmente através de cirurgia, aberta ou laparoscópica. A urgência da intervenção é maior em casos de obstrução e infecção do trato urinário superior, impondo deterioração da função renal, dor ou vômitos, anúria ou severo grau de obstrução em rim único ou transplantado. A melhor modalidade terapêutica a ser empregada deve ser individualizada.


Patients with ureteral calculi typically present renal colic due to urinary tract obstruction. Once the acute pain is controlled a therapeutic plan should be established. The unenhanced CT is the best diagnostic test. Ureteral calculi treatment can be either clinical or interventive. Alpha-adrenergic blockers are the most frequently prescribed drugs for the so-called medical expulsion therapy. Stones with a low probability of spontaneous passage (on the basis of their size and location) should be treated using such interventions as extracorporeal shock wave lithotripsy, ureteroscopy, or open surgery, in selected cases. Urgent intervention is indicated for a patient with an obstructed, infected upper urinary tract, impending renal deterioration, intractable pain or vomiting, anuria, or high-grade obstruction in a solitary or transplanted kidney. The best therapeutic approach should be selected on an individual basis.


Assuntos
Humanos , Cólica/etiologia , Cólica/terapia , Litotripsia , Ureterolitíase/diagnóstico , Ureterolitíase/terapia , Ureteroscopia
11.
Clin J Am Soc Nephrol ; 3(5): 1446-52, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18480302

RESUMO

BACKGROUND AND OBJECTIVES: This study aimed to determine the expression of osteoprotegerin, receptor activator of nuclear factor kappaB ligand, interleukin-1alpha, transforming growth factor-beta, and basic fibroblast growth factor in stone-forming patients with idiopathic hypercalciuria. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Immunohistochemical analysis was performed in undecalcified bone samples previously obtained from 36 transiliac bone biopsies of patients who had idiopathic hypercalciuria and whose histomorphometry had shown lower bone volume, increased bone resorption, and prolonged mineralization lag time. RESULTS: Bone expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin was significantly higher in patients with idiopathic hypercalciuria versus control subjects. Transforming growth factor-beta immunostaining was lower in patients with idiopathic hypercalciuria than in control subjects and correlated directly with mineralization surface. Interleukin-1alpha and basic fibroblast growth factor staining did not differ between groups. Receptor activator of nuclear factor kappaB ligand bone expression was significantly higher in patients who had idiopathic hypercalciuria and exhibited higher versus normal bone resorption. CONCLUSION: A higher expression of receptor activator of nuclear factor kappaB ligand in bone tissue suggests that increased bone resorption in patients with idiopathic hypercalciuria is mediated by receptor activator of nuclear factor kappaB ligand. Osteoprotegerin bone expression might have been secondarily increased in an attempt to counteract the actions of receptor activator of nuclear factor kappaB ligand. The low bone expression of transforming growth factor-beta could contribute to the delayed mineralization found in such patients.


Assuntos
Reabsorção Óssea/etiologia , Hipercalciúria/metabolismo , Ílio/química , Ligante RANK/análise , Adulto , Densidade Óssea , Reabsorção Óssea/metabolismo , Reabsorção Óssea/patologia , Estudos de Casos e Controles , Feminino , Fator 2 de Crescimento de Fibroblastos/análise , Humanos , Hipercalciúria/complicações , Hipercalciúria/patologia , Ílio/patologia , Imuno-Histoquímica , Interleucina-1alfa/análise , Masculino , Pessoa de Meia-Idade , Osteoprotegerina/análise , Fator de Crescimento Transformador beta/análise , Regulação para Cima
12.
J Bone Miner Metab ; 26(1): 110-3, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18095073

RESUMO

Immunohistochemistry of undecalcified bone sections embedded in methyl methacrylate (MMA) is not commonly employed because of potential destruction of tissue antigenicity by highly exothermic polymerization. The aim of the present study was to describe a new technique in which a quick decalcification of bone sections embedded in MMA improves the results for immunohistochemistry. The quality of interleukin 1alpha (IL-1alpha) immunostaining according to the present method was better than the conventional one. Immunostaining for osteoprotegerin (OPG) and the receptor activator of NF-kappaB ligand (RANKL) in bone sections of chronic kidney disease patients with mineral bone disorders (CKD-MBD) was stronger than in controls (postmortem healthy subjects). The present study suggested that this method is easy, fast, and effective to perform both histomorphometry and immunohistochemistry in the same bone fragment, yielding new insights into pathophysiological aspects and therapeutic approaches in bone disease.


Assuntos
Osso e Ossos/citologia , Técnica de Descalcificação/métodos , Imuno-Histoquímica/métodos , Metilmetacrilato , Doenças Ósseas/patologia , Humanos , Ílio/patologia , Falência Renal Crônica/patologia , Inclusão do Tecido/métodos
13.
Urol Res ; 34(5): 329-37, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16896690

RESUMO

Metabolic evaluation of stone-forming (SF) patients is based on the determination of calcium, oxalate, citrate, uric acid and other parameters in 24-h urine samples under a random diet. A reliable measurement of urinary oxalate requires the collection of urine in a receptacle containing acid preservative. However, urinary uric acid cannot be determined in the same sample under this condition. Therefore, we tested the hypothesis that the addition of preservatives (acid or alkali) after urine collection would not modify the results of those lithogenic parameters. Thirty-four healthy subjects (HS) were submitted to two non-consecutive collections of 24-h urine. The first sample was collected in a receptacle containing hydrochloric acid (HCl 6 N) and the second in a dry plastic container, with HCl being added as soon as the urine sample was received at the laboratory. Additionally, 34 HS and 34 SF patients collected a spot urine sample that was divided into four aliquots, one containing HCl, another containing sodium bicarbonate (NaHCO(3 )5 g/l), and two others in which these two preservative agents were added 24 h later. Urinary oxalate, calcium, magnesium, citrate, creatinine and uric acid were determined. Urinary parameters were also evaluated in the presence of calcium oxalate or uric acid crystals. Mean values of all urinary parameters obtained from previously acidified 24-h urine samples did not differ from those where acid was added after urine collection. The same was true for spot urine samples, with the exception of urinary citrate that presented a slight albeit significant change of 5.9% between samples in HS and 3.1% in SF. Uric acid was also not different between pre- and post-alkalinized spot urine samples. The presence of crystals did not alter these results. We concluded that post-delivery acidification or alkalinization of urine samples does not modify the measured levels of urinary oxalate, calcium, magnesium, creatinine and uric acid, and that the change on citrate was not relevant, hence allowing all parameters to be determined in a single urine sample, thus avoiding the inconvenience and cost of multiple 24-h urine sample collections.


Assuntos
Química Clínica/métodos , Cálculos Renais/urina , Preservação Biológica/métodos , Ácidos , Adulto , Álcalis , Cálcio/urina , Ácido Cítrico/urina , Creatinina/urina , Cristalização , Feminino , Humanos , Cálculos Renais/química , Magnésio/urina , Masculino , Oxalatos/urina
14.
Ren Fail ; 27(2): 155-61, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15807179

RESUMO

The estrogen receptor (ER) gene has been considered as a candidate genetic marker for osteoporosis, and PvuII and XbaI polymorphisms of the ERalpha gene have been associated with low bone mineral density (BMD). We investigated whether ER polymorphism could predict the response of BMD in 28 postmenopausal women on hemodialysis with marked osteopenia or osteoporosis, randomized to receive raloxifene, a selective estrogen receptor modulator (SERM), or placebo for 1 year. BMD was assessed by dual X-ray absorptiometry and PvuII and XbaI restriction fragment-length polymorphism of the ER gene was determined using polymerase chain reaction. Baseline lumbar spine or femoral neck BMD parameters were not different between patients presenting either homozygous PP or xx when compared with heterozygous Pp or Xx genotypes. After 1 year, patients on raloxifene, presenting with PP or xx genotypes (but not those with Pp or Xx), showed a significantly higher mean lumbar spine BMD (0.942 +/- 0.18 vs. 0.925 +/- 0.17 g/cm2, p < .01) and lower serum pyridinoline (19.7 +/- 9.7 vs. 30.6 +/- 16.5 nmol/L, p < .02) when compared with baseline values. No changes were detected in the placebo-treated patients or in the femur neck sites. In conclusion, after 1 year on raloxifene, postmenopausal osteoporotic women on chronic hemodialysis, homozygous for the P or x (PP or xx) alleles of the ER, exhibited a better lumbar spine BMD response and decreased serum pyridinoline values when compared with heterozygous women (Pp or Xx), suggesting that ERalpha allelic variants may explain, at least in part, the different outcomes after treatment of osteoporosis with SERM.


Assuntos
Cloridrato de Raloxifeno/uso terapêutico , Receptores de Estrogênio/genética , Diálise Renal , Moduladores Seletivos de Receptor Estrogênico/uso terapêutico , Idoso , Densidade Óssea , Método Duplo-Cego , Feminino , Genótipo , Humanos , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Polimorfismo Genético , Pós-Menopausa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...